General Instructions
Oxitan Injection is given in multiple cycles. It is essential to receive every scheduled dose and make a note of the next scheduled dose. Close the monitoring of blood cells counts and kidney function.
When Not to Use?
Allergy
Not suggested in patients with known allergy to this Injection or other platinum-containing compounds.
Severe myelosuppression
Not recommended for patients with low white blood cell and platelet count.
General warnings
This medicine may cause serious kidney injury. The risk may grow if taken with aminoglycoside antibiotics. Close observation of serum creatinine, urea, and sodium levels is mandatory.
This drug may cause the hearing problem which is more common in children. Audiometric testing should be executed before beginning the treatment and also before every dose. Any symptoms of the hearing problem should be described to the doctor.
This medicine may cause severe skin reactions. Finish the treatment if any symptoms of allergy shows and do not restart.
This medication may lower the white blood cells and platelets. Close monitoring of blood cell count is required. Do not begin the treatment if the cell count is low.
The chances of happening infections are more in patients receiving this drug. Hold the chemotherapy and begin with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close tracking of the body temperature and the blood cell count is necessary.
Warnings for special population
Pregnancy
Oxitan Injection is not recommended for pregnant women.
Breastfeeding
This medicine is not recommended for breastfeeding women.
